Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab


  • Rekha Mehta
  • Jayadev Raju
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_2817-2


Hormones are complex chemical messengers that bind with high affinity to specific cellular receptors to activate single or multiple signal transduction pathway(s) leading to growth, differentiation, embryogenesis or other biological processes. More than one hormone may work in concert to fulfill a physiological function. Hormones, through their capacity to influence cell growth and differentiation, may further modify the response of the body to carcinogens, the biological behavior of established tumors, and overall cancer risk. Hormones, therefore, play an important role in both the genesis and treatment of cancer.


Hormone-dependent malignancy has been most extensively studied in steroid hormone responsive organs. The steroid hormones, androgens, estrogens (Estradiol; Estrogenic Hormones and cancer) and progestins (Progestin), are implicated as key regulators in the development and the cancer process in the breast (Breast Cancer), prostate (Prostate Cancer...


Androgen Receptor Endometrial Cancer Gastrointestinal Stromal Tumor GnRH Agonist Gastrointestinal Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Bosland MC (2000) The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39–66CrossRefPubMedGoogle Scholar
  2. Darbre PD (ed) (2015) Endocrine disruption and human health. Elsevier, Amsterdam/Boston/Heidelberg/London/New York/Oxford/Paris/SanDiego/San Francisco/Singapore/Sydney/Tokyo, pp 1–377Google Scholar
  3. Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z (2015) Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis 36(Suppl 1):S254–S296CrossRefPubMedPubMedCentralGoogle Scholar
  4. Jia M, Dahlman-Wright K, Gustafsson JÅ (2015) Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab 29(4):557–568CrossRefPubMedGoogle Scholar
  5. Kunz PL (2015) Carcinoid and neuroendocrine tumors: building on success. J Clin Oncol 33(16):1855–1863CrossRefPubMedGoogle Scholar
  6. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378–455CrossRefPubMedPubMedCentralGoogle Scholar
  7. Yen PM (2015) Classical nuclear hormone receptor activity as a mediator of complex biological responses: a look at health and disease. Best Pract Res Clin Endocrinol Metab 29(4):517–528CrossRefPubMedGoogle Scholar

See Also

  1. (2012) Risk factor. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3310. doi:10.1007/978-3-642-16483-5_5111Google Scholar
  2. (2012) Differentiation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1113. doi:10.1007/978-3-642-16483-5_1616Google Scholar
  3. (2012) Initiation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1865. doi:10.1007/978-3-642-16483-5_3057Google Scholar
  4. (2012) Menopause. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2236. doi:10.1007/978-3-642-16483-5_3636Google Scholar

Copyright information

© Her Majesty the Queen in Right of Canada 2015

Authors and Affiliations

  1. 1.Regulatory Toxicology Research Division, Bureau of Chemical SafetyFood Directorate, HPFB, Health CanadaOttawaCanada